ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Clinical Supply Chain at Isomorphic Labs - ApplyBlast

Clinical Supply Chain

Isomorphic Labs

25 days ago

4.4 on Glassdoor

Cambridge, Massachusetts, United States

Hybrid

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Isomorphic Labs is seeking a proactive Clinical Supply Chain colleague to lead end-to-end clinical trial material planning, vendor management, and global distribution operations. This role serves as the clinical supply authority within a lean Pharmaceutical Sciences & CMC Manufacturing team, partnering with Clinical Operations to reimagine how new medicines are brought to patients. The position is designed for growth, acting as the foundational architect of clinical supply operations as the company's pipeline advances.

Responsibilities

Lead end-to-end clinical trial material planning and global distribution operations
Manage vendor relationships and oversee clinical packaging, labeling, and depot logistics
Implement temperature monitoring solutions and triage excursions to ensure product stability

Skills

Qualifications

Bachelor's degree in Supply Chain Management, Logistics, Life Sciences, Chemical/Industrial Engineering, Pharmacy, or a related disciplineMaster's degree in Supply Chain Management, Logistics, Life Sciences, Chemical/Industrial Engineering, Pharmacy, or a related discipline

About Isomorphic Labs

isomorphiclabs.com

Headquarters

London, England, United Kingdom

Company Size

51-200 employees

Founded

2021

View Profile

Isomorphic Labs is an AI-driven drug discovery company that applies frontier machine learning to reimagine the drug discovery process. Building on advances such as DeepMind’s AlphaFold, it uses protein-structure prediction, generative modeling, and computational biology to uncover deeper biological insights, design candidate molecules, and accelerate target selection. The company develops an integrated computational platform and partners with biopharma to translate in silico predictions into experimental programs aimed at faster, de‑risked development of life‑changing medicines. Its teams combine machine learning, biology, and chemistry expertise to shorten discovery timelines and increase the pace of therapeutic breakthroughs.